Related Experiment Video

Updated: Jan 19, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.2K

RAF kinases are stabilized and required for dendritic cell differentiation and function

Kristina Riegel1, Janine Schlöder2, Marco Sobczak2

  • 1Cell Biology Unit, University Medical Center Mainz, JGU-Mainz, Mainz, Germany.

Cell Death and Differentiation
|September 22, 2019
PubMed

Insights

RAF kinases are crucial for dendritic cell activation and T cell responses, with distinct roles from MEK1/2. This finding impacts the clinical use of RAF-MAPK inhibitors in cancer immunotherapy.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • RAF kinases (ARAF, BRAF, CRAF) activate the RAF-MEK1/2-ERK1/2 (MAPK) pathway.
  • The role of RAF kinases in immune responses, particularly in dendritic cells, is not well understood.
  • Dendritic cells (DCs) are key regulators of T cell-mediated antitumor immunity.

Purpose of the Study:

  • To investigate the function of RAF kinases and MEK1/2 in dendritic cells.
  • To determine the impact of RAF and MEK1/2 inhibition on DC activation and T cell responses.
  • To elucidate the distinct roles of RAF and MEK1/2 in immune regulation.

Main Methods:

  • Studied RAF kinase activity and protein levels during DC differentiation in mice and humans.
  • Utilized RAF and MEK1/2 inhibitors to assess their effects on DC activation.
  • Evaluated the impact of treated DCs on T cell activation and proliferation.

Main Results:

  • RAF kinases are active and stabilized during DC differentiation.
  • Inhibition of RAF kinases, but not MEK1/2, impaired DC activation.
  • RAF inhibition in DCs led to defects in T cell activation.
  • RAF and MEK1/2 are independently required for CD4+ T cell activation and proliferation.

Conclusions:

  • RAF kinases and MEK1/2 play distinct roles in regulating DC function.
  • RAF kinase inhibition impacts DC-mediated T cell responses.
  • Findings have implications for the clinical application of RAF-MAPK pathway inhibitors in cancer immunotherapy.

More Related Videos

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro06:12

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

3.8K
An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets09:09

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

Published on: April 18, 2016

15.9K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K